AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph Morton5 days ago
Medical and Pharmaceutical FDA clears Median Technologies lung-nodule risk assessment software The Median system reported 93.3 per cent sensitivity and 92.4 per cent specificity when identifying malignant lung nodules Joseph MortonMarch 16, 2026
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026
Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026
Medical and Pharmaceutical BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample Joseph MortonFebruary 12, 2026
Medical and Pharmaceutical Nearly four in ten global cancer cases are preventable, WHO analysis finds Researchers at the International Agency for Research on Cancer examined data from 185 countries to quantify preventable cancer risk Joseph MortonFebruary 4, 2026
Medical and Pharmaceutical Olympus rolls out advanced SecureFlex EUS biopsy needle in U.S. market The SecureFlex needle supports endoscopic ultrasound-guided fine needle biopsy Joseph MortonJanuary 28, 2026
AI and Autonomy BioMark earns peer-reviewed validation for AI-driven lung cancer detection model BioMark’s accepted paper describes a predictive model built on metabolomic pathway data rather than single biomarkers Joseph MortonJanuary 21, 2026